{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Not+applicable+for+study&page=3", "query": { "intervention": "Not applicable for study", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 327, "total_pages": 33, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Not+applicable+for+study&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Not+applicable+for+study&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T19:43:32.383Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05747105", "title": "A Sleep Extension Pilot Study in Adults With Obesity", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Sleep", "Weight, Body", "Eating Behavior", "Blood Pressure", "Quality of Life" ], "interventions": [ { "name": "Sleep Extension", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 0, "start_date": "2023-02-07", "completion_date": "2024-01", "has_results": false, "last_update_posted_date": "2023-05-19", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05747105" }, { "nct_id": "NCT07266740", "title": "PURSUIT: A Technologically Augmented School-based Program to Improve Child Coping and Prevent Substance Use.", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pediatric Pain", "Anxiety", "Mood", "Stress", "Feasibility Studies", "Acceptability", "Health Promotion", "Online Mental Health Program" ], "interventions": [ { "name": "PURSUIT", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Michigan State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "8 Years to 18 Years" }, "enrollment_count": 100, "start_date": "2026-11", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 1, "location_summary": "Grand Rapids, Michigan", "locations": [ { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07266740" }, { "nct_id": "NCT05755035", "title": "A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Primary Immunodeficiency Diseases (PID)" ], "interventions": [ { "name": "TAK-881", "type": "BIOLOGICAL" }, { "name": "HYQVIA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 65, "start_date": "2023-10-24", "completion_date": "2026-01-20", "has_results": true, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 15, "location_summary": "Irvine, California • Walnut Creek, California • Denver, Colorado + 12 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Macon", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05755035" }, { "nct_id": "NCT02649166", "title": "Responsive Deep Brain Stimulator for Essential Tremor", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Essential Tremor" ], "interventions": [ { "name": "Deep brain stimulation", "type": "DEVICE" }, { "name": "Closed-loop deep brain stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 20, "start_date": "2017-02-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-01-09", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02649166" }, { "nct_id": "NCT05203172", "title": "The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "Binimetinib", "type": "DRUG" }, { "name": "Encorafenib", "type": "DRUG" }, { "name": "Vemurafenib", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Cetuximab", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Bevacizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2022-07-05", "completion_date": "2032-06-30", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Atlanta, Georgia • Boston, Massachusetts + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05203172" }, { "nct_id": "NCT06825871", "title": "Automated Inhaler Monitoring for Asthma Medication Usage", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Smart Inhaler Monitoring Platform for Asthma Management", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 20, "start_date": "2025-12-01", "completion_date": "2026-06-26", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06825871" }, { "nct_id": "NCT06691867", "title": "Integrative Training Program for Pediatric Sickle Cell Pain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "I-STRONG", "type": "BEHAVIORAL" }, { "name": "Enhanced Usual Care (EUC)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Years to 18 Years" }, "enrollment_count": 155, "start_date": "2025-01-08", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2025-11-14", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 4, "location_summary": "Hartford, Connecticut • Atlanta, Georgia • Cincinnati, Ohio", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06691867" }, { "nct_id": "NCT05582707", "title": "Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Intracerebral Haemorrhage, Intraventricular" ], "interventions": [ { "name": "Pioglitazone 15mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1, "start_date": "2023-05-08", "completion_date": "2025-12-25", "has_results": true, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05582707" }, { "nct_id": "NCT01923311", "title": "Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acquired Immune Deficiency Syndrome (AIDS)", "HIV Infections" ], "interventions": [ { "name": "EVG", "type": "DRUG" }, { "name": "Background regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Weeks", "maximum_age": "17 Years", "sex": "ALL", "summary": "4 Weeks to 17 Years" }, "enrollment_count": 31, "start_date": "2013-08-26", "completion_date": "2017-11-03", "has_results": true, "last_update_posted_date": "2018-08-09", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 3, "location_summary": "Aurora, Colorado • Durham, North Carolina • Memphis, Tennessee", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01923311" }, { "nct_id": "NCT03339401", "title": "The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adenovirus" ], "interventions": [ { "name": "Standard of Care", "type": "OTHER" }, { "name": "Brincidofovir", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "25 Years", "sex": "ALL", "summary": "2 Months to 25 Years" }, "enrollment_count": 29, "start_date": "2017-12-22", "completion_date": "2019-05-10", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-10-17T19:43:32.383Z", "location_count": 11, "location_summary": "Los Angeles, California • San Francisco, California • Chicago, Illinois + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03339401" } ] }